Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered
Study highlights the ability of the Vaxzevria vaccine in inducing robust mucosal antibody responses, especially in COVID-19-recovered individuals, showcasing a notable defense against various SARS-CoV-2